1. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. Issue 10336 (30th April 2022) Authors: Fizazi, Karim; Foulon, Stéphanie; Carles, Joan; Roubaud, Guilhem; McDermott, Ray; Fléchon, Aude; Tombal, Bertrand; Supiot, Stéphane; Berthold, Dominik; Ronchin, Philippe; Kacso, Gabriel; Gravis, Gwenaëlle; Calabro, Fabio; Berdah, Jean-François; Hasbini, Ali; Silva, Marlon; Thiery-Vuillemin, Antoi... Journal: Lancet Issue: Volume 399:Issue 10336(2022) Page Start: 1695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. Issue 8 (6th June 2022) Authors: Vano, Yann‐Alexandre; Phan, Letuan; Gravis, Gwenaelle; Korakis, Iphigénie; Schlürmann, Friederike; Maillet, Denis; Bennamoun, Mostefa; Houede, Nadine; Topart, Delphine; Borchiellini, Delphine; Barthelemy, Philippe; Ratta, Raffaele; Ryckewaert, Thomas; Hasbini, Ali; Hans, Sophie; Emambux, Sheik; C... Journal: International journal of cancer Issue: Volume 151:Issue 8(2022) Page Start: 1335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database. (January 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Le Moulec, Sylvestre; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; De Giorgi, Ugo; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 125(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Le Moulec, Sylvestre; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; De Giorgi, Ugo; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer. (July 2018) Authors: Thibault, Constance; Eymard, Jean-Christophe; Birtle, Alison; Krainer, Michael; Baciarello, Giulia; Fléchon, Aude; Le Moulec, Sylvestre; Spaeth, Dominique; Laguerre, Brigitte; Caffo, Orazio; Deville, Jean-Laurent; Beuzeboc, Phillipe; Hasbini, Ali; Gross-Goupil, Marine; Helissey, Carole; Bennamoun... Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Moulec, Sylvestre Le; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; Giorgi, Ugo De; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients. Issue 6 (1st August 2019) Authors: Voog, Eric; Campillo‐Gimenez, Boris; Elkouri, Claude; Priou, Franck; Rolland, Frederic; Laguerre, Brigitte; Elhannani, Chaza; Merrer, Jacques; Pfister, Christian; Sevin, Emmanuel; L'Haridon, Tifenn; Hasbini, Ali; Moise, Laura; Le Rol, Annick; Malhaire, Jean Pierre; Delva, Remy; Vauléon, Elodie; C... Journal: International journal of cancer Issue: Volume 146:Issue 6(2020) Page Start: 1643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol. (May 2023) Authors: Rogé, Maximilien; Pointreau, Yoann; Sargos, Paul; Meyer, Emmanuel; Schick, Ulrike; Hasbini, Ali; Rio, Emmanuel; Bera, Guillaume; Ruffier, Amandine; Quivrin, Magali; Chasseray, Mathieu; Latorzeff, Igor; Martin, Etienne; Guimas, Valentine; Pommier, Pascal; Leroy, Thomas; Ronchin, Philippe; Lepinoy,... Journal: Clinical and translational radiation oncology Issue: Volume 40(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Issue 6 (June 2016) Authors: Carrie, Christian; Hasbini, Ali; de Laroche, Guy; Richaud, Pierre; Guerif, Stéphane; Latorzeff, Igor; Supiot, Stéphane; Bosset, Mathieu; Lagrange, Jean-Léon; Beckendorf, Véronique; Lesaunier, François; Dubray, Bernard; Wagner, Jean-Philippe; N'Guyen, Tan Dat; Suchaud, Jean-Philippe; Créhange, Gil... Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗